NCT02049528View on ClinicalTrials.gov

Study to Evaluate Pharmacokinetics of Single Oral Doses of Formulated and Non-Formulated CC-122, and Food Effect Study

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 16, 2014

Primary Completion Date

February 2, 2014

Study Completion Date

February 8, 2014

Conditions
Clinical Pharmacology, Healthy Male Volunteer Study
Interventions
DRUG

CC-122

CC-122

DRUG

CC-122

CC-122

DRUG

CC-122

CC-122

Trial Locations (1)

32117

Covance Clinical Development Services, Daytona Beach

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY